Shares of Concord Medical Services Hldg Ltd (NYSE:CCM) have been assigned a consensus broker rating score of 3.70 (Sell) from the one analysts that cover the company, Zacks Investment Research reports. One investment analyst has rated the stock with a sell rating.
Analysts have set a 12-month consensus price target of $2.00 for the company and are anticipating that the company will post ($0.03) earnings per share for the current quarter, according to Zacks. Zacks has also assigned Concord Medical Services an industry rank of 67 out of 256 based on the ratings given to related companies.
Separately, Zacks Investment Research upgraded shares of Concord Medical Services from a “sell” rating to a “hold” rating in a research report on Thursday.
A hedge fund recently raised its stake in Concord Medical Services stock. Wedbush Securities Inc. raised its position in Concord Medical Services Hldg Ltd (NYSE:CCM) by 28.5% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 21,432 shares of the company’s stock after purchasing an additional 4,757 shares during the period. Wedbush Securities Inc.’s holdings in Concord Medical Services were worth $60,000 as of its most recent filing with the SEC. 1.79% of the stock is owned by hedge funds and other institutional investors.
Shares of Concord Medical Services stock traded down $0.10 during trading on Monday, hitting $2.69. 2,800 shares of the company’s stock traded hands, compared to its average volume of 9,476. The company has a current ratio of 1.41, a quick ratio of 1.41 and a debt-to-equity ratio of 0.90. The business’s fifty day simple moving average is $2.59. Concord Medical Services has a twelve month low of $1.85 and a twelve month high of $3.84. The firm has a market cap of $116.22 million, a P/E ratio of -2.24 and a beta of -0.16.
About Concord Medical Services
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. The company's services comprise linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, CyberKnife robotic radiosurgery system, proton beam therapy systems, and diagnostic imaging services.
See Also: What is a capital gains distribution?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Concord Medical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Concord Medical Services and related companies with MarketBeat.com's FREE daily email newsletter.